169 related articles for article (PubMed ID: 4969832)
1. Treatment of chronic schizophrenic patients with haloperidol and chlorpromazine combined.
Jones B; Lehmann HE; Saxena BM; Ban TA
Curr Ther Res Clin Exp; 1968 Jun; 10(6):276-8. PubMed ID: 4969832
[No Abstract] [Full Text] [Related]
2. Clinical effects of L-5-hydroxytryptophan administration in chronic schizophrenic patients.
Bigelow LB; Walls P; Gillin JC; Wyatt RJ
Biol Psychiatry; 1979 Feb; 14(1):53-67. PubMed ID: 369623
[TBL] [Abstract][Full Text] [Related]
3. Effects of two butyrophenone compounds on acute schizophrenic patients: speculation on the neurophysiologic sites of action.
Gallant DM; Bishop M; Guerrero-Figueroa R
Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:53-60. PubMed ID: 4860981
[No Abstract] [Full Text] [Related]
4. Alpha methyldopa-chlorpromazine interaction in schizophrenic patients.
Chouinard G; Pinard G; Prenoveau Y; Tetreault L
Curr Ther Res Clin Exp; 1973 Feb; 15(2):60-72. PubMed ID: 4632508
[No Abstract] [Full Text] [Related]
5. Treatment of acute exacerbations in chronic schizophrenic patients.
Towler ML; Wick PH
Int J Neuropsychiatry; 1967 Aug; 3():Suppl l:61-7. PubMed ID: 4860982
[No Abstract] [Full Text] [Related]
6. Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance.
Singh MM
Dis Nerv Syst; 1976 Apr; 37(4):191-6. PubMed ID: 767080
[TBL] [Abstract][Full Text] [Related]
7. BL-KR140: a controlled evaluation in chronic schizophrenic patients previously stabilized on chlorpromazine.
Gallant DM; Bishop MP; O'Meallie L
Curr Ther Res Clin Exp; 1967 Aug; 9(8):447-50. PubMed ID: 4962470
[No Abstract] [Full Text] [Related]
8. CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients.
Villeneuve C; Ananth JV; Ban TA; Lehmann HE
Curr Ther Res Clin Exp; 1970 Apr; 12(4):223-9. PubMed ID: 4985943
[No Abstract] [Full Text] [Related]
9. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
Reschke RW
Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
[TBL] [Abstract][Full Text] [Related]
10. Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia.
Serafetinides EA; Willis D; Clark ML
J Nerv Ment Dis; 1972 Nov; 155(5):366-9. PubMed ID: 4563078
[No Abstract] [Full Text] [Related]
11. A controlled evaluation of haloperidol, chlorpromazine, and sodium amobarbital: intramuscular short-term use in acute psychotic patients.
Shopsin B; Hekimian LJ; Gershon S; Floyd A
Curr Ther Res Clin Exp; 1969 Sep; 11(9):561-73. PubMed ID: 4980886
[No Abstract] [Full Text] [Related]
12. Controlled comparison of therapeutic effects of oxyprothepin and chlorpromazine in schizophrenic patients [proceedings].
Vinar O; Taussigová D; Bastecký J; Vinarová E
Act Nerv Super (Praha); 1976; 18(3):212-4. PubMed ID: 12642
[No Abstract] [Full Text] [Related]
13. A comparison of the relative efficacy of Serenace and chlorpromazine in the treatment of chronic schizophrenics.
Rompel H; Segal H
J Int Med Res; 1978; 6(2):126-32. PubMed ID: 344086
[TBL] [Abstract][Full Text] [Related]
14. [Morphologic anomalies of lymphocytes in schizophrenic patients in relation to various therapeutic methods].
Belloni F
Acta Neurol (Napoli); 1967; 22(5):689-700. PubMed ID: 5608897
[No Abstract] [Full Text] [Related]
15. [Clinical experimentation with desipramine with statistical control].
Kammerer M; Wartel R; Gurfein L; Weil J; Wysoki V; Gelb F
Ann Med Psychol (Paris); 1968 Jan; 1(1):109-13. PubMed ID: 4870813
[No Abstract] [Full Text] [Related]
16. Treatment of acute and chronic psychoses with haloperidol: review of clinical results.
Ban TA
Curr Ther Res Clin Exp; 1969 May; 11(5):284-8. PubMed ID: 4977400
[No Abstract] [Full Text] [Related]
17. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
Wilson LG; Roberts RW; Gerber CJ; Johnson MH
J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
[TBL] [Abstract][Full Text] [Related]
18. [Controlled comparison of nalorphine with haloperidol in acute psychoses of the schizophrenic group ].
Svestka J; Náhunek K; Cesková E; Rysánek R
Cesk Psychiatr; 1982 Jun; 78(3):159-66. PubMed ID: 6749311
[No Abstract] [Full Text] [Related]
19. A standard-controlled clinical study with benzquinamide in the treatment of chronic schizophrenic patients.
Amin MM; Ban TA; Lehmann HE
Psychopharmacol Bull; 1977 Jul; 13(3):20-1. PubMed ID: 329325
[No Abstract] [Full Text] [Related]
20. Fluoxetine augmentation of haloperidol in chronic schizophrenia.
Shim JC; Kelly DL; Kim YH; Yoon YR; Park JH; Shin JG; Conley RR
J Clin Psychopharmacol; 2003 Oct; 23(5):520-2. PubMed ID: 14520132
[No Abstract] [Full Text] [Related]
[Next] [New Search]
